Tag: Biotech
India’s healthcare & pharma deals surge in Q3 2025 driven by...
The surge was driven by seven high value deals worth USD 2.6 billion, reflecting renewed investor confidence in scale and consolidation plays across pharma, biotech, and hospital segments
Thermo Fisher Scientific expands Bengaluru R&D Hub with Rs 160 Crore...
The center will create 100+ jobs in Karnataka in the coming years
Signature genes that predict T-Cell expansion in cancer immunotherapy
By tracking immune cells in tumors over time, researchers identify genes that predict CD8+ T cell expansion in the tumor
Lupin unveils strategic partnership program to expand reach of its long-acting...
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
WHO prequalifies Shantha Biotech’s ‘Shanchol’ Oral Cholera Vaccine to ensure global...
This milestone enables global procurement agencies such as UNICEF, Gavi, and PAHO to source Shanchol® for use in countries where cholera remains a major public health challenge
Dr Renu Swarup elected as fellow of INSA, honoured for leadership...
Over her three-decade career she has contributed significantly in areas such as Biotechnology policy development, including the Biotechnology Vision (2001) and subsequent national strategies
Takeda India launches ‘For You, With You IBD’ app to support...
New patient services initiative aims to empower more than a million IBD patients in India through tracking, education and daily support tools
Jim Anthony appointed as CCO & President of Parexel Biotech
Strategic leadership appointment strengthens company’s commercial approach to drive continued growth and deliver long-term value
Thermo Fisher Scientific announces crucial investments in India at Biopharma Conclave...
Advanced facilities in Hyderabad will provide technology access, skill-building
DBT backs 3D tissue models to replace animal testing amid evolving...
While the Department of Biotechnology supports cutting-edge non-animal methods for drug discovery and disease modelling, key gaps remain in validation protocols, regulatory engagement, and national data repositories.